TRIM33 PHD and bromodomain (human recombinant)

TRIM33 PHD and bromodomain (human recombinant)

CAT N°: 14661
Price:

3,651.00 3,103.35

TRIM33 (TIF1-?) is a multi-domain regulator of transcription. It contains a RING domain with E3 ubiquitin ligase activity, two B-boxes, a coiled-coil domain, a PHD domain, and a bromodomain. TRIM33 is necessary for embryogenesis, and mice homozygous for TRIM33 knock-out do not survive to embryonic day 9.5.{24403} TRIM33 is targeted to DNA by its tandem PHD and bromodomain which bind histone 3 at trimethylated lysine 9 (H3K9me3) and acetylated lysine 18 (H3K18ac), respectively.{24405} TRIM33 represses TGF-? signaling by sequestering SMAD2/3, and by ubiquitinating SMAD4.{24402,24407,24406} The TRIM33-SMAD2/3 complex upregulates transcription at sites of H3K9 trimethylation. During the DNA damage response, TRIM33 targets Amplified in Liver Cancer 1 (ALC1) to sites of DNA damage.{24404} Deletion of either the PHD or bromodomain of TRIM33 prevents localization of TRIM33 to sites of DNA damage.{24404} This protein product contains the PHD and bromodomains of TRIM33.

We also advise you